Friday, April 06, 2007

The N-end rule


Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12142-9.
The N-end rule: functions, mysteries, uses.
Varshavsky A.


Science. 1986 Oct 10;234(4773):179-86.
In vivo half-life of a protein is a function of its amino-terminal residue.
Bachmair A,Finley D,Varshavsky A.

When a chimeric gene encoding a ubiquitin-beta-galactosidase fusion protein is expressed in the yeast Saccharomyces cerevisiae, ubiquitin is cleaved off the nascent fusion protein, yielding a deubiquitinated beta-galactosidase (beta gal). With one exception (proline), this cleavage takes place regardless of the nature of the amino acid residue of beta gal at the ubiquitin-beta gal junction, thereby making it possible to expose different residues at the amino-termini of the otherwise identical beta gal proteins. The beta gal proteins thus designed have strikingly different half-lives in vivo, from more than 20 hours to less than 3 minutes, depending on the nature of the amino acid at the amino-terminus of beta gal. The set of individual amino acids can thus be ordered with respect to the half-lives that they confer on beta gal when present at its amino-terminus (the "N-end rule"). The currently known amino-terminal residues in long-lived, noncompartmentalized intracellular proteins from both prokaryotes and eukaryotes belong exclusively to the stabilizing class as predicted by the N-end rule. The function of the previously described posttranslational addition of single amino acids to protein amino-termini may also be accounted for by the N-end rule. Thus the recognition of an amino-terminal residue in a protein may mediate both the metabolic stability of the protein and the potential for regulation of its stability.


Trends Cell Biol. 2007 Feb 14;
The N-end rule pathway for regulated proteolysis: prokaryotic and eukaryotic strategies.
Mogk A,Schmidt R,Bukau B (summary of the N-end rule)





Comments:
I saw you talking about ubiquitin protein, so I thought you might be interested in Science Magazine's current webinar regarding disease treatment:
Science Magazine's Webinar: The Ubiquitin-Proteasome Pathway
 
Post a Comment



<< Home

This page is powered by Blogger. Isn't yours?